Loading…

Low serum omentin levels in the elderly population with Type 2 diabetes and polyneuropathy

Aims To investigate the hypothesis that high serum levels of omentin, an adipokine with anti‐inflammatory, insulin‐sensitizing and cardioprotective properties, may be related to a lower risk of diabetic sensorimotor polyneuropathy. Methods The association between serum omentin level and polyneuropat...

Full description

Saved in:
Bibliographic Details
Published in:Diabetic medicine 2015-11, Vol.32 (11), p.1479-1483
Main Authors: Herder, C., Bongaerts, B. W. C., Ouwens, D. M., Rathmann, W., Heier, M., Carstensen-Kirberg, M., Koenig, W., Thorand, B., Roden, M., Meisinger, C., Ziegler, D.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Aims To investigate the hypothesis that high serum levels of omentin, an adipokine with anti‐inflammatory, insulin‐sensitizing and cardioprotective properties, may be related to a lower risk of diabetic sensorimotor polyneuropathy. Methods The association between serum omentin level and polyneuropathy was estimated in people aged 61–82 years with Type 2 diabetes (47 with and 168 without polyneuropathy) from the population‐based KORA F4 study. The presence of clinical diabetic sensorimotor polyneuropathy was defined as bilateral impairment of foot vibration perception and/or foot pressure sensation. Omentin levels were determined by enzyme‐linked immunosorbent assay. Results Serum omentin level was inversely associated with polyneuropathy after adjustment for age, sex, height, waist circumference, hypertension, total cholesterol, smoking, alcohol intake and physical activity [odds ratio 0.45 (95% CI 0.21–0.98); P = 0.043]. Although omentin was positively correlated with adiponectin (r = 0.55, P 
ISSN:0742-3071
1464-5491
DOI:10.1111/dme.12761